RPSG Ventures will acquire Clarionix Healthcare and amalgamate Woodlands Multispeciality Hospital. The hospital undertaking will then be transferred via a slump sale for ₹400 crore.
RPSG Ventures Restructures Healthcare Business
250.08 crore Revenue (WMHL FY25-26) | 458.15 crore Total Assets (WMHL)
Reader Takeaway: Consolidation aims for focused healthcare operations, but regulatory approvals and potential dilution are key.
What just happened
RPSG Ventures Limited is undertaking a significant corporate restructuring of its healthcare business. The company has approved the acquisition of 100% of Clarionix Healthcare Private Limited for ₹0.01 crore. Additionally, Woodlands Multispeciality Hospital Limited (WMHL) will be amalgamated into RPSG Ventures.
Following the amalgamation, the hospital and nursing undertaking will be transferred to a wholly-owned subsidiary (RPSG WOS) through a slump sale valued at ₹400 crore.
Why this matters
This move aims to consolidate RPSG Ventures' healthcare operations onto a single, regulated, listed platform. Management believes this will enhance institutional credibility and corporate governance. It is also intended to improve access to capital by leveraging public market infrastructure for future funding needs. Segregating the hospital business into a subsidiary allows for dedicated management and potential strategic investments without affecting the parent company's structure.
The backstory
As of March 31, 2026, Woodlands Multispeciality Hospital reported total assets of ₹458.15 crore and a net worth of ₹326.97 crore, with FY2025-26 revenue of ₹250.08 crore. RPSG Ventures had significantly larger total assets of ₹4,336.61 crore and a net worth of ₹1,610.86 crore, with FY2025-26 revenue of ₹270.50 crore.
What changes now
The scheme involves issuing Optionally Convertible Redeemable Preference Shares (OCRPS) to eligible WMHL members. For every equity share held in WMHL, 500 OCRPS (face value ₹10 each) will be issued, convertible into 5 equity shares. If not converted within 78 months, these will be redeemed at par. A 6% non-cumulative coupon is payable if conversion doesn't happen within 18 months.
Risks to watch
Implementation depends on approvals from the National Company Law Tribunal (NCLT), stock exchanges, SEBI, and shareholders. Investors should monitor the conversion of OCRPS, as it could lead to equity dilution for existing shareholders.
Peer comparison
(No peer comparison data available in the filing.)
Context metrics (time-bound)
- Acquisition of Clarionix Healthcare: ₹0.01 crore.
- Slump sale consideration for hospital undertaking: ₹400 crore.
- WMHL financials as of March 31, 2026: Total Assets ₹458.15 cr, Net Worth ₹326.97 cr, Revenue ₹250.08 cr.
- RPSG Ventures financial position as of March 31, 2026: Total Assets ₹4,336.61 cr, Net Worth ₹1,610.86 cr, Revenue ₹270.50 cr.
What to track next
Investors should closely follow the progress of regulatory approvals, particularly from the NCLT. The company's ability to attract strategic or PE investors to the ring-fenced subsidiary will also be a key indicator.